Are hemostasis and thrombosis two sides of the same coin?

Journal of Experimental Medicine

Volumn 203, Issue 3, 2006, Pages 493-495

  Colman, Robert W ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; BLOOD CLOTTING FACTOR 12; FIBRIN; RECOMBINANT BLOOD CLOTTING FACTOR 7A; THROMBIN;

ARTERY THROMBOSIS; BLEEDING; BLOOD CLOTTING; BLOOD CLOTTING FACTOR 12 DEFICIENCY; DISSEMINATED INTRAVASCULAR CLOTTING; DRUG TARGETING; GENETIC DISORDER; HEMOPHILIA; HEMOSTASIS; HUMAN; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTECTION; PROTEIN TARGETING; REVIEW; STROKE; THROMBOCYTE; THROMBOSIS; VENOUS THROMBOEMBOLISM;

ANIMALS; BLOOD COAGULATION FACTOR INHIBITORS; BLOOD VESSELS; BRAIN ISCHEMIA; FACTOR XI DEFICIENCY; FACTOR XII; FACTOR XII DEFICIENCY; FEMALE; FIBRIN; HEMOSTASIS; MALE; MICE; MICE, KNOCKOUT; THROMBOSIS;

EID: 33645062426     PISSN: 00221007     EISSN: 00221007     Source Type: Journal    
DOI: 10.1084/jem.20060217     Document Type: Review

References (21)

1. Kleinschnitz, C., G. Stoll, M. Bendszus, K. Schuh, H.-U. Pauer, P. Burfeind, C. Renné, D. Gailani, B. Nieswandt, and T. Renné. 2006. Targeting coagulation factor XII provides protection from pathological thrombosis in cerebral ischemia without interfering with hemostasis. J. Exp. Med. 203:513-518.
2. Mackman, N. 2004. Role of tissue factor in hemostasis, thrombosis, and vascular development. Arterioscler. Thromb. Vasc. Biol. 24: 1015-1022.
3. Osterud, B., and S.I. Rapaport. 1977. Activation of factor IX by the reaction product of tissue factor and factor VII: additional pathway for initiating blood coagulation. Proc. Natl. Acad. Sci. USA. 74:5260-5264.
4. Gailani, D., and G.J. Broze Jr. 1991. factor XI activation in a revised model of blood coagulation. Science. 253:909-912.
5. Renne, T., M. Pozgajova, S. Gruner, K. Schuh, H.U. Pauer, P. Burfeind, D. Gailani, and B. Nieswandt. 2005. Defective thrombus formation in mice lacking coagulation factor XII. J. Exp. Med. 202:271-281.
6. Choudhri, T.F., B.L. Hoh, H.G. Zerwes, C.J. Prestigiacomo, S.C. Kim, E.S. Connolly Jr., and R.W. Colman. 1998. Reduced microvascular thrombosis and improved outcome in acute murine stroke by inhibiting GP IIb/IIIa receptor-mediated platelet aggregation. J. Clin. Invest. 102:1301-1310.
7. Davie, E.W., and O.D. Ratnoff. 1964. Waterfall sequence for intrinsic blood clotting. Science. 145:1310-1312.
8. Smith, S.A., N.J. Mutch, D. Baskar, P. Rohloff, R. Docampo, and J.H. Morrissey. 2006. From the cover: Polyphosphate modulates blood coagulation and fibrinolysis. Proc. Natl. Acad. Sci. USA. 103:903-908.
9. Radcliffe, R., A. Bagdasarian, R. Colman, and Y. Nemerson. 1977. Activation of bovine factor VII by Hageman factor fragments. Blood. 50:611-617.
10. Veldman, A., M. Hoffman, and S. Ehrenforth. 2003. New insights into the coagulation system and implications for new therapeutic options with recombinant factor VIIa. Curr. Med. Chem. 10:797-811.
11. Habermann, B., K. Hochmuth, L. Hovy, I. Scharrer, and A.H. Kurth. 2004. Management of haemophilic patients with inhibitors in major orthopaedic surgery by immunadsorption, substitution of factor VIII and recombinant factor VIIa (NovoSeven): a single centre experience. Haemophilia. 10:705-712.
12. Levi, M., M. Peters, and H.R. Buller. 2005. Efficacy and safety of recombinant factor VIIa for treatment of severe bleeding: a systematic review. Crit. Care Med. 33:883-890.
13. Kappelmayer, J., A. Bernabei, N. Gikakis, L.H. Edmunds Jr., and R.W. Colman. 1993. Upregulation of Mac-1 surface expression on neutrophils during simulated extracorporeal circulation. J. Lab. Clin. Med. 121:118-126.
14. Kappelmayer, J., A. Bernabei, L.H. Edmunds Jr., T.S. Edgington, and R.W. Colman. 1993. Tissue factor is expressed on monocytes during simulated extracorporeal circulation. Circ. Res. 72:1075-1081.
15. Hattori, T., M.M. Khan, R.W. Colman, and L.H. Edmunds Jr. 2005. Plasma tissue factor plus activated peripheral mononuclear cells activate factors VII and X in cardiac surgical wounds. J. Am. Coll. Cardiol. 46(4):707-713.
16. Khan, M.M.H., T. Hattori, S. Niewiarowski, L.H. Edmunds Jr., and R.W. Colman. 2006. Truncated and microparticle-free soluble tissue factor bound to peripheral monocytes preferentially activate factor VII. Thromb. Haemost. In press.
17. Miller, G., M. Silverberg, and A.P. Kaplan. 1980. Autoactivatability of human Hageman factor (factor XII). Biochem. Biophys. Res. Commun. 92:803-810.
18. Cochrane, C.G., S.D. Revak, and K.D. Wuepper. 1973. Activation of Hageman factor in solid and fluid phases. A critical role of kallikrein. J. Exp. Med. 138:1564-1583.
19. Pixley, R.A., R.A. DeLa Cadena, J.D. Page, N. Kaufman, E.G. Wyshock, A. Chang, F.B. Taylor, Jr., and R.W. Colman. 1993. The contact system contributes to hypotension but not disseminated intravascular coagulation in lethal bacteremia: In vivo use of a monoclonal anti-factor XII antibody to block contact activation in baboons. J. Clin. Invest. 91:61-68.
20. Colman, R.W., S.J. Robboy, and J.D. Minna. 1972. Disseminated intravascular coagulation (DIC): an approach. Am. J. Med. 52:679-689.
21. Mason, J.W., U. Kleeberg, P. Dolan, and R.W. Colman. 1970. Plasma kallikrein and Hageman factor in Gram-negative bacteremia. Ann. Intern. Med. 73:545-551.